Back to trial details

Intake questionnaire

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Applying to The University of Texas M. D. Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Metastatic Triple-Negative Breast Cancer?
3. Are you able to travel to Houston for study visits?